EP3806838A4 - Compositions pharmaceutiques comprenant des dérivés de poh - Google Patents

Compositions pharmaceutiques comprenant des dérivés de poh Download PDF

Info

Publication number
EP3806838A4
EP3806838A4 EP19818648.8A EP19818648A EP3806838A4 EP 3806838 A4 EP3806838 A4 EP 3806838A4 EP 19818648 A EP19818648 A EP 19818648A EP 3806838 A4 EP3806838 A4 EP 3806838A4
Authority
EP
European Patent Office
Prior art keywords
pharmaceutical compositions
poh
derivatives
poh derivatives
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19818648.8A
Other languages
German (de)
English (en)
Other versions
EP3806838A1 (fr
Inventor
Thomas Chen
Daniel Levin
Satish Puppali
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southern California USC
Original Assignee
Neonc Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/123,729 external-priority patent/US11077104B2/en
Application filed by Neonc Technologies Inc filed Critical Neonc Technologies Inc
Publication of EP3806838A1 publication Critical patent/EP3806838A1/fr
Publication of EP3806838A4 publication Critical patent/EP3806838A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP19818648.8A 2018-06-15 2019-06-17 Compositions pharmaceutiques comprenant des dérivés de poh Pending EP3806838A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862685450P 2018-06-15 2018-06-15
US16/123,729 US11077104B2 (en) 2010-08-27 2018-09-06 Pharmaceutical compositions comprising POH derivatives
PCT/US2019/037458 WO2019241770A1 (fr) 2018-06-15 2019-06-17 Compositions pharmaceutiques comprenant des dérivés de poh

Publications (2)

Publication Number Publication Date
EP3806838A1 EP3806838A1 (fr) 2021-04-21
EP3806838A4 true EP3806838A4 (fr) 2022-03-30

Family

ID=68842345

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19818648.8A Pending EP3806838A4 (fr) 2018-06-15 2019-06-17 Compositions pharmaceutiques comprenant des dérivés de poh

Country Status (3)

Country Link
EP (1) EP3806838A4 (fr)
CN (1) CN112469401A (fr)
WO (1) WO2019241770A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4323070A1 (fr) * 2021-04-16 2024-02-21 University Of Southern California Compositions pharmaceutiques comprenant des dérivés de poh

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020010128A1 (en) * 2000-04-13 2002-01-24 Parks Thomas P. Treatment of hyperproliferative, inflammatory and related mucocutaneous disorders using inhibitors of mevalonate synthesis and metabolism
JP4634694B2 (ja) * 2001-03-23 2011-02-16 ルイトポルド・ファーマシューティカルズ・インコーポレーテッド 脂肪アルコール薬物複合体
EP2042167A1 (fr) * 2007-09-26 2009-04-01 Aisa Therapeutics Utilisation d'un monoterpène pour induire la réparation tissulaire
WO2010091198A1 (fr) * 2009-02-06 2010-08-12 University Of Southern California Compositions thérapeutiques comprenant des monoterpènes
EP3685835A1 (fr) * 2010-08-27 2020-07-29 Neonc Technologies, Inc. Compositions pharmaceutiques comprenant des dérivés de poh
US9522918B2 (en) * 2015-02-12 2016-12-20 Neonc Technologies, Inc. Pharmaceutical compositions comprising perillyl alcohol derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
WO2019241770A1 (fr) 2019-12-19
EP3806838A1 (fr) 2021-04-21
CN112469401A (zh) 2021-03-09

Similar Documents

Publication Publication Date Title
EP3817722A4 (fr) Compositions pharmaceutiques comprenant du méloxicam
EP3565550A4 (fr) Compositions pharmaceutiques contenant du méloxicam
EP3641771A4 (fr) Compositions pharmaceutiques
EP3621621A4 (fr) Compositions pharmaceutiques contenant du méloxicam
EP4045480A4 (fr) Formulations pharmaceutiques
EP3452075A4 (fr) Composition pharmaceutique ophtalmique
AU2018302170A1 (en) Pharmaceutical compositions comprising entrectinib
EP3860585A4 (fr) Compositions thérapeutiques
EP3581183A4 (fr) Composition pharmaceutique pour oncothérapie
EP3672598A4 (fr) Compositions pharmaceutiques oculaires
EP3583943A4 (fr) Composition pharmaceutique
EP3946316A4 (fr) Compositions pharmaceutiques de cannabidiol
EP3851121A4 (fr) Composition pharmaceutique contenant un anticorps monoclonal anti-il-33 humain
EP3682016A4 (fr) Formulations pour l'administration de composés
EP3389633A4 (fr) Compositions pharmaceutiques comprenant un dérivé de phénylaminopyrimidine
EP3868371A4 (fr) Nouvelle composition pharmaceutique
EP3773613A4 (fr) Compositions pharmaceutiques contenant des polyrotaxanes
EP3720844A4 (fr) Compositions de médicaments
EP3646867A4 (fr) Composition pharmaceutique
EP3881841A4 (fr) Composition pharmaceutique
EP3886820B8 (fr) Formulations de capsules
EP3946296A4 (fr) Formulation pharmaceutique à libération prolongée
EP3873437A4 (fr) Formulations pharmaceutiques aqueuses
EP3824887A4 (fr) Préparation médicinale à usage externe
EP3646863A4 (fr) Composition pharmaceutique

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210113

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0031192000

Ipc: A61K0047540000

A4 Supplementary search report drawn up and despatched

Effective date: 20220301

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/00 20060101ALI20220223BHEP

Ipc: A61K 31/192 20060101ALI20220223BHEP

Ipc: A61P 29/00 20060101ALI20220223BHEP

Ipc: A61K 47/10 20170101ALI20220223BHEP

Ipc: A61K 31/231 20060101ALI20220223BHEP

Ipc: A61K 47/55 20170101ALI20220223BHEP

Ipc: A61K 47/54 20170101AFI20220223BHEP

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230517

P02 Opt-out of the competence of the unified patent court (upc) changed

Effective date: 20230529

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: UNIVERSITY OF SOUTHERN CALIFORNIA